SEARCH

SEARCH BY CITATION

References

  • Adamec R. and McKay D. (1993) Amygdala-kindling, anxiety, and corticotrophin releasing factor (crf.). Physiol. Behav. 53, 531545.
  • Adamec R. and Morgan H. D. (1994) The effect of kindling of different nuclei in the left and right amygdala on anxiety in the rat. Physiol. Behav. 55, 112.
  • Adamec R. and Young B. (2000) Neuroplasticity in specific limbic system circuits may mediate specific kindling induced changes in animal affect: implications for understanding anxiety associated with epilepsy. Neurosci. Biobehav. Rev. 24, 705723.
  • Alonso N. B., Ciconelli R. M., Da Silva T. I., Westphal-Guitti A. C., Azevedo A. M., Da Silva Noffs M. H., Caboclo L. O., Sakamoto A. C. and Targas Yacubian E. M. (2006) The Portuguese version of the Epilepsy Surgery Inventory (ESI-55): cross-cultural adaptation and evaluation of psychometric properties. Epilepsy Behav. 9, 126132.
  • Altshuler L., Rausch R., Delrahim S., Kay J. and Crandall P. (1999) Temporal lobe epilepsy, temporal lobectomy, and major depression. J. Neuropsychiatry Clin. Neurosci. 11, 436443.
  • Alvestad S., Hammer J., Eyjolfsson E., Qu H., Ottersen O. P. and Sonnewald U. (2007) Limbic structures show altered glial-neuronal metabolism in the chronic phase of kainate induced epilepsy. Neurochem. Res. (in press)
  • Asztely F.., Kokaia M., Olofsdotter K., Ortegren U. and Lindvall O. (2000) Afferent-specific modulation of short-term synaptic plasticity by neurotrophins in dentate gyrus. Eur. J. Neurosci. 12, 662669.
  • Asztely F., Ekstedt G., Rydenhag B. and Malmgren K. (2007) Long-term follow-up of the first 70 operated adults in the Goteborg epilepsy surgery series with respect to seizures, psychosocial outcome and use of anti-epileptic drugs. J. Neurol. Neurosurg. Psychiatry [Epub ahead of print].
  • Auer D. P., Putz B., Kraft E., Lipinski B., Schill J. and Holsboer F. (2000) Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol. Psychiatry 47, 305313.
  • Baker G. A. (2006) Depression and suicide in adolescents with epilepsy. Neurology 66, S5S12.
  • Baxendale S., Thompson P. J. and Duncan J. S. (2005) Epilepsy & depression: the effects of comorbidity on hippocampal volume – a pilot study. Seizure 14, 435438.
  • Beneyto M., Kristiansen L. V., Oni-Orisan A., McCullumsmith R. E. and Meador-Woodruff J. H. (2007) Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology [Epub ahead of print].
  • Ben-Menachem E. (2001) Vagus nerve stimulation, side effects, and long-term safety. J. Clin. Neurophysiol. 18, 415418.
  • Bhagwagar Z., Hinz R., Taylor M., Fancy S., Cowen P. and Grasby P. (2006) Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. Am. J. Psychiatry 163, 15801587.
  • Billups B. and Attwell D. (1996) Modulation of non-vesicular glutamate release by pH. Nature 379, 171174.
  • Binder D. K. and Steinhauser C. (2006) Functional changes in astroglial cells in epilepsy. Glia 54, 358368.
  • Blumer D., Montouris G. and Hermann B. (1995) Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J. Neuropsych. Clin. Neurosci. 7, 445456.
  • Blumer D., Montouris G. and Davies K. (2004) The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav. 5, 826840.
  • Boylan L. S., Flint L. A., Labovitz D. L., Jackson S. C., Starner K. and Devinsky O. (2004) Depression but not seizure frequency predicts quality of life in treatment resistant epilepsy. Neurology 62, 258261.
  • Brandt C., Potschka H., Loscher W. and Ebert U. (2003) N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainite model of temporal lobe epilepsy. Neuroscience 118, 727740.
  • Bremner J. D., Narayan M., Anderson E. R., Staib L. H., Miller H. L. and Charney D. S. (2000) Hippocampal volume reduction in major depression. Am. J. Psychiatry 152, 973981.
  • Bromfield E. B., Altshuler L. and Leiderman D. B. (1992) Cerebral metabolism and depression in patients with complex partial seizures. Arch. Neurol. 49, 617623.
  • Browning R. A., Wood A. V., Merrill M. A., Dailey J. W. and Jobe P. C. (1997) Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors. Eur. J. Pharmacol. 336, 16.
  • Bruchey A. K., Shumake J. and Gonzalez-Lima F. (2006) Network model of fear extinction and renewal functional pathways. Neuroscience [Epub ahead of print].
  • Brunner D. and Hen R. (1997) Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice. Ann. NY Acad. Sci. 836, 81105.
  • Cameron O. G. (2006) Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions. Essent. Psychopharmacol. 7, 2434.
  • Cammisuli S., Murphy M. P., Ikeda-Douglas C. J., Balkissoon V., Holsinger R. M., Head E., Michael M., Racine R. J. and Milgram N. W. (1997) Effects of extended electrical kindling on exploratory behavior and spatial learning. Behav. Brain Res. 89, 179190.
  • Caramaschi D., De Boer S. F. and Koolhaas J. M. (2007) Differential role of the 5-HT(1A) receptor in aggressive and non-aggressive mice: an across-strain comparison. Physiol. Behav. [Epub ahead of print].
  • Carroll B. J, Cassidy F., Naftolowitz D., Tatham N. E., Wilson W. H., Iranmanesh A., Liu P. Y. and Veldhuis J. D. (2007) Pathophysiology of hypercortisolism in depression. Acta Psychiatr. Scand. 433, S90S103.
  • Casse R., Rowe C. C., Newton M., Berlangieri S. U. and Scott A. M. (2002) Positron emission tomography and epilepsy. Mol. Imaging Biol. 4, 338351.
  • Cavalheiro E. A., Fernandes M. J., Turski L. and Naffah-Mazzacoratti M. G. (1994) Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus. Epilepsia 35, 111.
  • Cavazos J. E. and Cross D. J. (2006) The role of synaptic reorganization in mesial temporal lobe epilepsy. Epilepsy Behav. 83, 483493.
  • Cendes F., Cook M. J., Watson C., Andermann F., Fish D. R., Shorvon S. D., Bergin P., Free S., Dubeau F. and Arnold D. L. (1995) Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology 45, 20582064.
  • Chapman A. G. (2000) Glutamate and epilepsy. J. Nutr. 130, S1043S1045.
  • Chen B., Dowlatshahi D., MacQueen G. M., Wang J. F. and Young L. T. (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50, 260265.
  • Choi J. Y., Kim S. J., Hong S. B., Seo D. W., Hong S. C., Kim B. T. and Kim S. E. (2003) Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Eur. J. Nucl. Med. Mol. Imaging 304, 581587.
  • Colino A. and Halliwell J. V. (1987) Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin. Nature 328, 7377.
  • Conti F., Minelli A. and Melone M. (2004) GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications. Brain Res. Brain Res. Rev. 45, 196212.
  • Coulter D., McIntyre D. and Loscher W. (2002) Animal models of limbic epilepsies: what can they tell us? Brain Pathol. 12, 240256.
  • Coyle J. T. and Duman R. S. (2003) Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38, 157160.
  • D’Ambrosio R. (2006) Does glutamate released by astrocytes cause focal epilepsy? Epilepsy Curr. 6, 173176.
  • D’Mello G. D. and Steckler T. (1996) Animal models in cognitive behavioural pharmacology: an overview. Brain Res. Cogn. Brain Res. 3, 345352.
  • Danbolt N. C. (2001) Glutamate uptake. Progress Neurobiol. 65, 1105.
  • Davis M. (2006) Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am. Psychol. 61, 741756.
  • Delgado P. L. (2004) Common pathways of depression and pain. J. Clin. Psychiatry 65, S16S19.
  • Depaulis A., Helfer V., Deransart C. and Marescaux C. H. (1997) Anxiogenic-like consequences in animal models of complex partial seizures. Neurosci. Behav. Rev. 6, 767774.
  • Detour J., Schroeder H., Desor D. and Nehlig A. (2005) A 5-month period of epilepsy impairs spatial memory, decreases anxiety, but spares object recognition in the lithium-pilocarpine model in adult rats. Epilepsia 46, 499508.
  • Devinsky O., Barr W. B., Vickrey B. G. et al. (2005) Changes in depression and anxiety after resective surgery for epilepsy. Neurology 65, 17441749.
  • Dos Santos Jr J. G., Longo B. M., Blanco M. M., Menezes de Oliveira M. G. and Mello L. E. (2005) Behavioral changes resulting from the administration of cycloheximide in the pilocarpine model of epilepsy. Brain Res. 1066, 3748.
  • Douglas A. J. (2005) Central noradrenergic mechanisms underlying acute stress responses of the hypothalamo-pituitary-adrenal axis: adaptations through pregnancy and lactation. Stress 8, 518.
  • Drevets W. C. (2000) Neuroimaging studies of mood disorders. Biol. Psychiatry 48, 813829.
  • Drevets W. C., Frank E., Price J. C., Kupfer D. J., Holt D., Greer P. J., Huang Y., Gautier C. and Mathis C. (1999) PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 46, 13751387.
  • Dulay M. F., Schefft B. K., Fargo J. D., Privitera M. D. and Yeh H. S. (2004) Severity of depressive symptoms, hippocampal sclerosis, auditory memory, and side of seizure focus in temporal lobe epilepsy. Epilepsy Behav. 5, 522531.
  • Duman R. S. (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromol. Med. 5, 1125.
  • Duman R. S. and Monteggia L. M. (2006) A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59, 11161127.
  • Eid T., Thomas M. J., Spencer D. D., Runden-Pran E., Lai J. C., Malthankar G. V., Kim J. H., Danbolt N. C., Ottersen O. P. and De Lanerolle N. C. (2004) Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet 363, 2837.
  • Eid T., Lee T. S., Thomas M. J., Amiry-Moghaddem M., Bjornsen L. P., Spencer D. D., Agre P., Ottersen O. P. and De Lanerolle N. C. (2005) Loss of perivascular aquaporin 4 may underlie deficient water and K+ homeostatis in the human epileptogenic hippocampus. Proc. Natl. Acad. Sci. USA 102, 11931198.
  • Eid T., Hammer J., Runden-Pran E. et al. (2007) Increased expression of phosphate-activated glutaminase in hippocampal neurons in human mesial temporal lobe epilepsy. Acta Neuropathol. 113, 137152.
  • El-Hassar L., Milh M., Wendling F., Ferrand N., Esclapez M. and Bernard C. (2007) Cell domain-dependent changes in the glutamatergic and GABAergic drives during epileptogenesis in the rat CA1 region. J. Physiol. 578, 193211.
  • Ferrari P. F., Palanza P., Parmigiani S., De Almeida R. M. and Miczek K. A. (2005) Serotonin and aggressive behavior in rodents and nonhuman primates: predispositions and plasticity. Eur. J. Pharmacol. 526, 259273.
  • Forsgren L. and Nystrom L. (1999) An incident case referent study of epileptic seizures in adults. Epilepsy Res. 6, 6681.
  • Frodl T., Meisenzahl E., Zetsche T., Rottlender R., Born C., Groll C., Jäger M., Leinsinger G., Hahn K. and Möller H. J. (2002) Enlargement of the amygdala in patients with a first episode of major depression. Biol. Psychiatry 51, 708714.
  • Gajwani P., Forsthoff A., Muzina D., Amann B., Gao K., Elhaj O., Calabrese J. R. and Grunze H. (2005) Antiepileptic drugs in mood-disordered patients. Epilepsia 46, S38S44.
  • Gallagher B. B. (1987) Endocrine abnormalities in human temporal lobe epilepsy. Yale J. Biol. Med. 60, 9397.
  • Garakani A., Mathew S. J. and Charney D. S. (2006) Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J. Med. 73, 941949.
  • Garrido Sanabria E. R., Castaneda M. T., Banuelos C., Perez-Cordova M. G., Hernandez S. and Colom L. V. (2006) Septal GABAergic neurons are selectively vulnerable to pilocarpine-induced status epilepticus and chronic spontaneous seizures. Neuroscience 142, 871883.
  • Gascino G. D., Jack Jr C. R., Parisi J. E., Sharbrough F. W., Hirschhorn K. A., Meyer F. B., Marsh W. R. and O’Brien P. C. (1991) Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann. Neurol. 30, 3136.
  • Gilliam F., Hecimovic H. and Sheline Y. (2003) Psychiatric comorbidity, health, and function in epilepsy. Epilepsy Behav. 4, S26S30.
  • Giovacchini G., Toczek M. T., Bonwetsch R. et al. (2005) 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J. Nucl. Med. 46, 11281135.
  • Hajszan T. and MacLusky N. J. (2006) Neurologic links between epilepsy and depression in women: is hippocampal neuroplasticity the key? Neurology 66, S13S22.
  • Halonen T., Nissinen J. and Pitkanen A. (2001) Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats. Neuropharmacol. 40, 536550.
  • Harden C. L. (2002) The co-morbidity of depression and epilepsy. Neurology 59, S48S55.
  • Harden C. L. and Goldstein M. A. (2002) Mood disorders in patients with epilepsy: epidemiology and treatment. CNS Drugs 16, 291302.
  • Hargrave R., Martinez D. and Bernstein A. J. (1992) Fluoxetine-induced seizures. Psychosomatics 33, 236239.
  • Hasler G., Van Der Veen J. W., Tumonis T., Meyers N., Shen J. and Drevets W. C. (2007) Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 64, 193200.
  • Hecimovic H., Goldstein J. D., Sheline Y. I. and Gilliam F. G. (2003) Mechanisms of depression in epilepsy from a clinical perspective. Epilepsy Behav. 4, S25S30.
  • Helfer V., Deransart C., Marescaux C. and Depaulis A. (1996) Amygdala kindling in the rat: anxiogenic-like consequences. Neuroscience 73, 971978.
  • Helmstaedter C., Sonntag-Dillender M., Hoppe C. and Elger C. E. (2004) Depressed mood and memory impairment in temporal lobe epilepsy as a function of focus lateralization and localization. Epilepsy Behav. 5, 696701.
  • Henke P. G. and Sullivan R. M. (1985) Kindling in the amygdala and susceptibility to stress ulcers. Brain Res. Bull. 400, 360364.
  • Henry T. R. and Votaw J. R. (2004) The role of positron emission tomography with [18F]fluorodeoxyglucose in the evaluation of the epilepsies. Neuroimaging Clin. N. Am. 14, 517535.
  • Hermann B., Seidenberg M. and Bell B. (2000) Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 41, S31S41.
  • Hernandez E. J., Wiliams P. A. and Dudek F. E. (2002) Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia 43, 13371345.
  • Hertz L. (1979) Functional interactions between neurons and astrocytes. I. Turnover and metabolism of putative amino acid transmitters. Prog. Neurobiol. 13, 277323.
  • Hesdorffer D. C., Hauser W. A., Annegers J. F. and Gascino G. (2000) Major depression is a risk factor for seizures in older adults. Ann. Neurol. 47, 246249.
  • Hesdorffer D. C., Hauser W. A., Olafsson E., Ludvigsson P. and Kjartansson D. (2006) Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann. Neurol. 59, 3541.
  • Ho S. S., Consalvo D., Gilliam F., Faught E., Bilir E., Morawetz R. and Kuzniecky R. I. (1998) Amygdala atrophy and seizure outcome after temporal lobe epilepsy surgery. Neurology 5, 15021504.
  • Holmes K. H., Keele N. B., Arvanov V. L. and Shinnick-Gallagher P. (1996) Metabotropic glutamate receptor agonist-induced hyperpolarizations in rat basolateral amygdala neurons: receptor characterization and ion channels. J. Neurophysiol. 76, 30593069.
  • Hort J., Brozek G., Mares P., Langmeier M. and Komarek V. (1999) Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures. Epilepsia 40, 11771183.
  • Howell S., Westergaard G., Hoos B., Chavanne T. J., Shoaf S. E., Cleveland A., Snoy P. J., Suomi S. J. and Dee Higley J. (2007) Serotonergic influences on life-history outcomes in free-ranging male rhesus macaques. Am. J. Primatol. [Epub ahead of print].
  • Hughes C. R. and Keele N. B. (2006) Phenytoin normalizes exaggerated fear behavior in p-chlorophenylalanine (PCPA)-treated rats. Epilepsy Behav. 9, 557563.
  • Jacobsen J. P. and Mork A. (2006) Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res. 1110, 221225.
  • Jayanthi L. D. and Ramamoorthy S. (2005) Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J. 7, 728738.
  • Joo E. Y., Lee E. K., Tae W. S. and Hong S. B. (2004) Unitemporal vs bitemporal hypometabolism in mesial temporal lobe epilepsy. Arch. Neurol. 61, 10741078.
  • Jourdain P., Bergersen L. H., Bhaukaurally K., Bezzi P., Santello M., Domercq M., Matute C., Tonello F., Gundersen V. and Volterra A. (2007) Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci. 10, 331339.
  • Kalynchuk L. E. (2000) Long-term kindling in rats as a model for the study of interictal emotionality in temporal lobe epilepsy. Neurosci. Behav. Rev. 24, 691704.
  • Kalynchuk L. E., Pinel J. P. and Treit D. (1998) Long-term kindling and interictal emotionality in rats: effect of stimulation site. Brain Res. 779, 149157.
  • Kang N., Xu J., Xu Q., Nedergaard M. and Kang J. (2005) Astrocytic glutamate release–induced transient depolarization and epileptiform discharges in hippocampal CA1 pyramidal neurons. J. Neurophysiol. 94, 41214130.
  • Kang T. C., Kim D. S., Kwak S. E., Kim J. E., Won M. H., Kim D. W., Choi S. Y. and Kwon O. S. (2006) Epileptogenic roles of astroglial death and regeneration in the dentate gyrus of experimental temporal lobe epilepsy. Glia 54, 258271.
  • Kann O., Kovacs R., Njunting M., Behrens C. J., Otahal J., Lehmann T. N., Gabriel S. and Heinemann U. (2005) Metabolic dysfunction during neuronal activation in the ex vivo hippocampus from chronic epileptic rats and humans. Brain 128, 23962407.
  • Kanner A. M. (2003) Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol. Psychiatry 54, 388398.
  • Kanner A. M. (2006a) Epilepsy, suicidal behaviour, and depression: do they share common pathogenic mechanisms? Lancet Neurol. 5, 107108.
  • Kanner A. M. (2006b) Depression and epilepsy: a new perspective on two closely related disorders. Epilepsy Curr. 6, 141146.
  • Kanner A. M. and Balabanov A. (2002) Depression and epilepsy: how closely related are they? Neurology 58, S27S39.
  • Keele N. B. (2001) Phenytoin inhibits isolation-induced aggression specifically in rats with low serotonin. Neuroreport 12, 110712.
  • Keele N. B. (2005) The role of serotonin in impulsive and aggressive behaviors associated with epilepsy-like neuronal hyperexcitability in the amygdala. Epilepsy Behav. 7, 325335.
  • Kim M. A., Heo K., Choo M. K., Cho J. H., Park S. C., Lee J. D., Yun M., Park H. J. and Lee B. I. (2006) Relationship between bilateral temporal hypometabolism and EEG findings for mesial temporal lobe epilepsy: analysis of 18F-FDG PET using SPM. Seizure 15, 5663.
  • Kondziella D., Bidar A., Urfjell B., Sletvold O. and Sonnewald U. (2002) The pentylenetetrazole-kindling model of epilepsy in SAMP8 mice: behavior and metabolism. Neurochem. Int. 40, 413418.
  • Kondziella D., Hammer J., Sletvold O. and Sonnewald U. (2003) The pentylenetetrazole-kindling model of epilepsy in SAMP8 mice: glial-neuronal metabolic interactions. Neurochem. Int. 43, 629637.
  • Koyama R. and Ikegaya Y. (2005) To BDNF or not to BDNF: that is the epileptic hippocampus. Neuroscientist 11, 282287.
  • Koyama R., Yamada M. K., Fujisawa S., Katoh-Semba R., Matsuki N. and Ikegaya Y. (2004) Brain-derived neurotrophic factor induces hyperexcitable reentrant circuits in the dentate gyrus. J. Neurosci. 24, 72157224.
  • Kugaya A. and Sanacora G. (2005) Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr. 10, 808819.
  • Kuhn K. U., Quednow B. B., Thiel M., Falkai P., Maier W. and Elgerb C. E. (2003) Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressant. Epilepsy Behav. 4, 674679.
  • Kunz W. S., Kudin A. P., Vielhaber S., Blumcke I., Zuschratter W., Schramm J., Beck H. and Elger C. E. (2000) Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann. Neurol. 48, 766773.
  • Kuzniecky R., Ho S. S., Martin R., Faught E., Morawetz R., Palmer C. and Gilliam F. (1999) Temporal lobe developmental malformations and hippocampal sclerosis: epilepsy surgical outcome. Neurology 52, 479484.
  • Labiner D. M. and Ahern G. L. (2007) Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings. Acta Neurol. Scand. 115, 2333.
  • Larmet Y., Reibel S., Carnahan J., Nawa H., Marescaux C. and Depaulis A. (1995) Protective effects of brain-derived neurotrophic factor on the development of hippocampal kindling in the rat. Neuroreport 6, 19371941.
  • Lavretsky H., Ballmaier M., Pham D., Toga A. and Kumar A. (2007) Neuroanatomical characteristics of geriatric apathy and depression: a magnetic resonance imaging study. Am. J. Geriatr. Psychiatry 15, 386394.
  • Lee A. L., Ogle W. O. and Sapolsky R. M. (2002) Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord. 4, 117128.
  • Lemos J. C., Pan Y. Z., Ma X., Lamy C., Akanwa A. C. and Beck S. G. (2006) Selective 5-HT receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe. Eur. J. Neurosci. 12, 34153430.
  • Leonard B. E. (2005) The HPA and immune axes in stress: the involvement of the serotonergic system. Eur. Psychiatry 13, S302S306.
  • Letty S., Lerner-Natoli M. and Rondouin G. (1995) Differential impairments of spatial memory and social behavior in two models of limbic epilepsy. Epilepsia 36, 973982.
  • Li L. M., Cendes F., Andermann F. et al. (1999) Surgical outcome in patients with epilepsy and dual pathology. Brain 122, 799805.
  • Lieberman D. N. and Mody I. (1999) Properties of single NMDA receptor channels in human dentate gyrus granule cells. J. Physiol. 518, 5570.
  • Liu Q. S., Xu Q., Arcuino G., Kang J. and Nedergaard M. (2004) Astrocyte-mediated activation of neuronal kainate receptors. Proc. Natl Acad. Sci. USA 101, 31723177.
  • Lu K. T. and Gean P. W. (1998) Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation. Neuroscience 86, 729737.
  • Mahanty N. K. and Sah P. (1999) Excitatory synaptic inputs to pyramidal neurons of the lateral amygdala. Eur. J.Neurosci. 11, 12171222.
  • Malmgren K., Starmark J. E., Ekstedt G., Rosen H. and Sjoberg-Larsson C. (2002) Nonorganic and organic psychiatric disorders in patients after epilepsy surgery. Epilepsy Behav. 3, 6775.
  • Malthankar-Phatak G. H., De Lanerolle N., Eid T., Spencer D. D., Behar K. L., Spencer S. S., Kim J. H. and Lai J. C. (2006) Differential glutamate dehydrogenase (GDH) activity profile in patients with temporal lobe epilepsy. Epilepsia 47, 12921299.
  • Manno E. M., Sperling M. R., Ding X., Jaggi J., Alavi A., O’Connor M. J. and Reivich M. (1994) Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Neurology 44, 23312336.
  • Mason B. L. and Pariante C. M. (2006) The effects of antidepressants on the hypothalamic-pituitary-adrenal axis. Drug News Perspect. 19, 603608.
  • Mathern G. W., Babb T. L., Micevych P. E., Blanco C. E. and Pretorius J. K. (1997) Granule cell mRNA levels for BDNF, NGF, and NT-3 correlate with neuron losses or supragranular mossy fiber sprouting in the chronically damaged and epileptic human hippocampus. Mol. Chem. Neuropathol. 30, 5376.
  • Matthews K., Christmas D., Swan J. and Sorrell E. (2005) Animal models of depression: navigating through the clinical fog. Neurosci. Biobehav. Rev. 29, 503513.
  • Mauguiere F. and Ryvlin P. (2004) The role of PET in presurgical assessment of partial epilepsies. Epileptic Disord. 6, 193215.
  • Mayberg H. S. (2003) Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin. N. Am. 13, 805815.
  • McEwan B. S. (2005) Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 54, S20S23.
  • McIntyre D. C. (1978) Amygdala kindling and muricide rats. Physiol. Behav. 21, 4956.
  • Melo T. M., Nehlig A. and Sonnewald U. (2006) Metabolism is normal in astrocytes in chronically epileptic rats: a 13C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy. J. Cereb. Blood Flow Metab. 25, 12541264.
  • Merlet I., Ostrowsky K., Costes N., Ryvlin P., Isnard J., Faillenot I., Lavenne F., Dufournel D., Le Bars D. and Mauguiere F. (2004) 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. Brain 127, 900913.
  • Meschaks A., Lindstrom P., Halldin C., Farde L. and Savic I. (2005) Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy. Arch. Neurol. 62, 946960.
  • Mesquita A. R., Tavares H. B., Silva R. and Sousa N. (2006) Febrile convulsions in developing rats induce a hyperanxious phenotype later in life. Epilepsy Behav. 9, 401406.
  • Meyer J. H., Kapur S., Eisfeld B., Brown G. M., Houle S., DaSilva J., Wilson A. A., Rafi-Tari S., Mayberg H. S. and Kennedy S. H. (2001) The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am. J. Psychiatry 158, 7885.
  • Miller D. B. and O’Callaghan J. P. (2005) Aging, stress and the hippocampus. Ageing Res. Rev. 4, 123140.
  • Mirza Y., Tang J., Russell A., Banerjee S. P., Bhandari R., Ivey J., Rose M., Moore G. J. and Rosenberg D. R. (2004) Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. Am. Acad Child Adolesc. Psychiatry 43, 341348.
  • Moeller F. G., Barratt E. S., Dougherty D. M., Schmitz J. M. and Swann A. C. (2001) Psychiatric aspects of impulsivity. Am. J. Psychiatry 158, 17831793.
  • Monaco F., Cavanna A., Magli E., Barbagli D., Collimedaglia L., Cantello R. and Mula M. (2005) Obsessionality, obsessive–compulsive disorder, and temporal lobe epilepsy. Epilepsy Behav. 7, 491496.
  • Moresco R. M., Matarrese M. and Fazio F. (2006) PET and SPET molecular imaging: focus on serotonin system. Curr. Top. Med. Chem. 6, 20272034.
  • Mueller S. G., Laxer K. D., Schuff N. and Weiner M. W. (2007) Voxel-based T2 relaxation rate measurements in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia 48, 220228.
  • Mula M., Trimble M. R. and Sander J. W. (2003) The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia 44, 15731577.
  • Muller B., Qu H., Garseth M., White L. R., Aasly J. and Sonnewald U. (2000) Amino acid neurotransmitter metabolism in neurones and glia following kainite injection in rats. Neurosci. Lett. 279, 169172.
  • Murray K. D., Isackson P. J., Eskin T. A., King M. A., Montesinos S. P., Abraham L. A. and Roper S. N. (2000) Altered mRNA expression for brain-derived neurotrophic factor and type II calcium/calmodulin-dependant protein kinase in the hippocamapus of patients with intractable temporal lobe epilepsy. J. Comp. Neurol. 418, 411422.
  • Neder L., Valente V., Carlotti Jr C. G., Leite J. P., Assirati J. A., Paco-Larson M. L. and Moreira J. E. (2002) Glutamate NMDA receptor subunit R1 and GAD mRNA expression in human temporal lobe epilepsy. Cell. Mol. Neurobiol. 22, 689698.
  • Nedergaard M., Takano T. and Hansen A. J. (2002) Beyond the role of glutamate as a neurotransmitter. Nat. Rev. Neurosci. 3, 748755.
  • Nestler E. J., Barrot M., DiLeone R. J., Eisch A. J., Gold S. J. and Monteggia L. M. (2002) Neurobiology of depression. Neuron 34, 1325.
  • Neugebauer V., Keele N. B. and Shinnick-Gallagher P. (1997) Epileptogenesis in vivo enhances the sensitivity of inhibitory presynaptic metabotropic glutamate receptors in basolateral amygdala neurons in vitro. J. Neurosci. 17, 983995.
  • Neumeister A., Bain E., Nugent A. C., Carson R. E., Bonne O., Luckenbaugh D. A., Eckelman W., Herscovitch P., Charney D. S. and Drevets W. C. (2004) Reduced serotonin type 1A receptor binding in panic disorder. J. Neurosci. 24, 589591.
  • Nieminen S. A., Sirvio J., Teittinen K., Pitkanen A., Airaksinen M. M. and Riekkinen P. (1992) Amygdala kindling increased fear-response, but did not impair spatial memory in rats. Physiol. Behav. 51, 845849.
  • Nutt D. J. (2006) The role of dopamine and noradrenalin in depression and antidepressant treatment. J. Clin. Psychiatry 67, S3S8.
  • Ongur D., Drevets W. C. and Price J. L. (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl Acad. Sci. USA 95, 1329013295.
  • Oquendo M. A., Placidi G. P., Malone K. M. et al. (2003) Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch. Gen. Psychiatry 60, 1422.
  • Osehobo P., Adams B., Sazgar M., Xu Y., Racine R. J. and Fahnestock M. (1999) Brain-derived neurotrophic factor infusion delays amygdala and perforant path kindling without affecting paired-pulse measures of neuronal inhibition in adult rats. Neuroscience 92, 13671375.
  • Palucha A. (2006) Are compounds acting at metabotropic glutamate receptors the answer to treating depression? Expert Opin. Investig. Drugs 15, 15451553.
  • Parent J. M., Von Dem Bussche N. and Lowenstein D. H. (2006) Prolonged seizures recruit caudal subventricular zone glial progenitors into the njured hippocampus. Hippocampus 16, 321328.
  • Pasini A., Tortorella A. and Gale K. (1996) The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res. 724, 8488.
  • Paul I. A. and Skolnick P. (2003) Glutamate and depression: clinical and preclinical studies. Ann. N. Y. Acad. Sci. 1003, 250272.
  • Petroff O. A., Errante L. D., Rothman D. L., Kim J. H. and Spencer D. D. (2002a) Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia 43, 703710.
  • Petroff O. A., Errante L. D., Rothman D. L., Kim J. H. and Spencer D. D. (2002b) Neuronal and glial metabolite content of the epileptogenic human hippocampus. Ann. Neurol. 52, 635642.
  • Phelps E. A. and LeDoux J. E. (2005) Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48, 175187.
  • Pintor L., Bailles E., Fernandez-Egea E. et al. (2007) Psychiatric disorders in temporal lobe epilepsy patients over the first year after surgical treatment. Seizure 16, 218225.
  • Pompili M., Girardi P. and Tatarelli R. (2006) Death from suicide versus mortality from epilepsy in the epilepsies: a meta-analysis. Epilepsy Behav. 4, 641648.
  • Popova N. K. (2006) From genes to aggressive behavior: the role of serotonergic system. Bioessays 2006, 495503.
  • Prasher V. P. (1993) Seizure associated with fluoxetine therapy. Seizure 2, 315317.
  • Pritchard P. B. (1991) Effects of seizures on hormones. Epilepsia 32, S46S50.
  • Pugliese A. M., Passani M. B. and Corradetti R. (1998) Effect of the selective 5-HT1A receptor antagonist WAY 100635 on the inhibition of e.p.s.ps produced by 5-HT in the CA1 region of rat hippocampal slices. Br. J. Pharmacol. 124, 93100.
  • Pulsipher D. T., Seidenberg M., Jones J. and Hermann B. (2006) Quality of life and comorbid medical and psychiatric conditions in temporal lobe epilepsy. Epilepsy Behav. 3, 510514.
  • Qu H., Eloqayli H., Muller B., Aasly J. and Sonnewald U. (2003) Glial-neuronal interactions following kainate injection in rats. Neurochem. Int. 42, 101106.
  • Quiske A., Helmstaedter C., Lux S. and Elger C. E. (2000) Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res. 39, 121125.
  • Rainnie D. G. (1999) Serotonergic modulation of neurotransmission in the rat basolateral amygdala. J. Neurophysiol. 82, 6985.
  • Rainnie D. G., Asprodini E. K. and Shinnick-Gallagher P. (1991) Inhibitory transmission in the basolateral amygdala. J. Neurophysiol. 66, 9991009.
  • Rajkowska G. and Miguel-Hidalgo J. J. (2007) Gliogenesis and glial pathology in depression. CNS Neurol. Disord. Drug Targets 6, 219233.
  • Ramboz S., Saudou F., Amara D. A., Belzung C., Segu L., Misslin R., Buhot M. C. and Hen R. (1996) 5-HT1B receptor knock out--behavioral consequences. Behav. Brain Res. 73, 305312.
  • Rasmuson S., Andrew R., Nasman B., Seckl J. R., Walker R. B. and Olsson T. (2001) Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer’s disease. Biol. Psychiatry 49, 547552.
  • Reibel S., Larmet Y., Carnahan J., Marescaux C. and Depaulis A. (2000a) Brain-derived neurotrophic factor delays hippocampal kindling in the rat. Neuroscience 100, 777788.
  • Reibel S., Vivien-Roels B., Le B. T., Larmet Y., Carnahan J., Marescaux C. and Depaulis A. (2000b) Overexpression of neuropeptide Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting. Eur. J. Neurosci. 12, 595605.
  • Reuber M., Andersen B., Elger C. E. and Helmstaedter C. (2004) Depression and anxiety before and after temporal lobe epilepsy surgery. Seizure 13, 129135.
  • Richardson E. J., Griffith H. R., Martin R. C., Paige A. L., Stewart C. C., Jones J., Hermann B. P. and Seidenberg M. (2007) Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy. Epilepsy Behav. 10, 242249.
  • Roch C., Leroy C., Nehlig A. and Namer I. J. (2002) Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine model. Epilepsia 43, 11291136.
  • Rogan M. T., Staubli U. V. and LeDoux J. E. (1997) Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390, 604607.
  • Rogawski M. A. (2005) Astrocytes get in the act in epilepsy. Nat. Med. 11, 919920.
  • Russo-Neustadt A. A. and Chen M. J. (2005) Brain-derived neurotrophic factor and antidepressant activity. Curr. Pharm. Des. 11, 14951510.
  • Salzberg M., Taher T., Davie M., Carne R., Hicks R. J., Cook M., Murphy M., Vinton A. and O’Brien T. J. (2006) Depression in temporal lobe epilepsy surgery patients: an FDG-PET study. Epilepsia 47, 21252130.
  • Sanacora G., Kendell S. F., Levin Y., Simen A. A., Fenton L. R., Coric V. and Krystal J. H. (2007) Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biol. Psychiatry 61, 822825.
  • Sapolsky R. M. (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57, 925935.
  • Sargent P. A., Kjaer K. H., Bench C. J., Rabiner E. A., Messa C., Meyer J., Gunn R. N., Grasby P. M. and Cowen P. J. (2000) Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry 57, 174180.
  • Savic I., Lindstrom P., Gulyas B., Halldin C., Andree B. and Farde L. (2004) Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 62, 13431351.
  • Scharfman H. E. (2005) Brain-derived neurotrophic factor and epilepsy-a missing link? Epilepsy Curr. 5, 8388.
  • Scharfman H. E., Goodman J. H., Sollas A. L. and Croll S. D. (2002) Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp. Neurol. 174, 201214.
  • Schousboe A. (2003) Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission. Neurochem. Res. 28, 347352.
  • Schubert M., Siegmund H., Pape H. C. and Albrecht D. (2005) Kindling-induced changes in plasticity of the rat amygdala and Hippocamopus. Learn. Mem. 12, 520526.
  • Seiffert E., Dreier J. P., Ivens S., Bechmann I., Tomkins O., Heinemann U. and Friedman A. (2004) Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci. 24, 78297836.
  • Semah F. (2002) Temporopolar metabolic abnormalities in temporal lobe epilepsies. Epileptic Disord. 4, S41S49.
  • Semah F., Baulac M., Hasboun D., Frouin V., Mangin J. F., Papageorgiou S., Leroy-Willig A., Philippon J., Laplane D. and Samson Y. (1995) Is interictal temporal hypometabolism related to mesial temporal sclerosis? A positron mission tomography/magnetic resonance imaging confrontation. Epilepsia 36, 447456.
  • Shank R. P., Bennett G. S., Freytag S. O. and Campbell G. L. (1985) Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res. 329, 364367.
  • Sheline Y. I. (2003) Neuroimaging studies of mood disorder effects on the brain. Biol. Psychiatry 54, 338352.
  • Sheline Y. I., Wang P. W., Gado M. H., Csernansky J. G. and Vannier M. W. (1996) Hippocampal atrophy in recurrent major depression. Proc. Natl Acad. Sci. USA 93, 39083913.
  • Sheline Y. I., Gado M. H. and Price J. L. (1998) Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 9, 50345043.
  • Sheline Y. I., Sanghavi M., Mintun M. A. and Gado M. H. (1999) Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J. Neurosci. 19, 50345043.
  • Sher L., Carballo J. J., Grunebaum M. F., Burke A. K., Zalsman G., Huang Y. Y., Mann J. J. and Oquendo M. A. (2006) A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disord. 8, 543550.
  • Shirayama Y., Chen A. C., Nakagawa S., Russell D. S. and Duman R. S. (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22, 32513261.
  • Siuciak J. A., Lewis D. R., Wiegand S. J. and Lindsay R. M. (1997) Antidepressant- like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56, 131137.
  • Siva N. (2005) Astrocytes have a key role in epilepsy. Lancet Neurol. 4, 601.
  • Smythies J. (2005) Section III. The noradrenalin system. Int. Rev. Neurobiol. 64, 173211.
  • Sokolowski J. D. and Seiden L. S. (1999) The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential-reinforcement-of-low-rate 72-second operant schedule in the rat. Psychopharmacol. 147, 153161.
  • Sonnewald U. and Kondziella D. (2003) Neuronal glial interaction in different neurological diseases studied by ex vivo 13C NMR spectroscopy. NMR Biomed. 16, 424429.
  • Spencer S. (2007) Epilepsy: clinical observations and novel mechanisms. Lancet Neurol. 6, 1416.
  • Stachowicz K., Chojnacka-Wojcik E., Klak K. and Pilc A. (2006) Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABA(A) signaling. Pharmacol. Rep. 58, 820826.
  • Stachowicz K., Chojnacka-Wojcik E., Klak K. and Pilc A. (2007) Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent. Neuropharmacol. 52, 306312.
  • Stanford M. S., Helfritz L. E., Conklin S. M., Villemarette-Pittman N. R., Greve K. W., Adams D. and Houston R. J. (2005) A comparison of anticonvulsants in the treatment of impulsive aggression. Exp. Clin. Psychopharmacol. 13, 7277.
  • Szabo G., Kartarova Z., Hoertnagl B., Somogyi R. and Sperk G. (2000) Differential regulation of adult and embryonic glutamate decarboxylases in rat dentate granule cells after kainate-induced limbic seizures. Neuroscience 100, 287295.
  • Szyndler J., Wierzba-Bobrowicz T., Skorzewska A., Maciejak P., Walkowiak J., Lechowicz W., Turzynska D., Bidzinski A. and Plaznik A. (2005) Behavioral, biochemical and histological studies in a model of pilocarpine-induced spontaneous recurrent seizures. Pharmacol. Biochem. Behav. 81, 1523.
  • Takeshita H., Kawahara R., Nagabuchi T., Mizukawa R. and Hazama H. (1986) Serum prolactin and growth hormone concentrations after various epileptic seizures. Jpn. J. Psychiatry Neurol. 40, 617623.
  • Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G. and Popoli M. (2006) Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol. Rev. 58, 115134.
  • Tata D. A., Marciano V. A. and Anderson B. J. (2006) Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. J. Comp. Neurol. 498, 363374.
  • Tebartz van Elst L., Woermann F. G., Lemieux L. and Trimble M. R. (1999) Amygdala enlargement in dysthymia: a volumetric study of patients with temporal lobe epilepsy. Biol. Psychiatry 46, 16141623.
  • Tebartz van Elst L., Woermann F., Lemieux L. and Trimble M. R. (2000) Increased amygdala volumes in female and depressed humans: a quantitative magnetic resonance imaging study. Neurosci. Lett. 281, 103106.
  • Then Bergh F., Kumpfel T., Grasser A., Rupprecht R., Holsboer F. and Trenkwalder C. (2001) Combined treatment with corticosetroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double-blind trial. J. Clin. Endocrinol. Metab. 86, 16101615.
  • Thome-Souza M. S., Kuczynski E. and Valente K. D. (2007) Sertraline and fluoxetine: Safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav. [Epub ahead of print].
  • Tian G. F., Azmi H., Takano T. et al. (2005) An astrocytic basis of epilepsy. Nat. Med. 11, 973981.
  • Tobianski R. I. and Lloyd G. G. (1995) ECG seizure threshold and fluoxetine. Br. J. Psychiatry 166, 263270.
  • Toczek M. T., Carson R. E., Lang L. et al. (2003) PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 60, 749756.
  • Tordera R. M., Totterdell S., Wojcik S. M., Brose N., Elizalde N., Lasheras B. and Del Rio J. (2007) Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur. J. Neurosci. 25, 281290.
  • Tran P. V., Bymaster F. P., McNamara R. K. and Potter W. Z. (2003) Dual monoamine modulation for improved treatment of major depressive disorder. J. Clin. Psychopharmacol. 23, 7886.
  • Verkhratsky A. and Toescu E. C. (2006) Neuronal-glial networks as substrate for CNS integration. J. Cell. Mol. Med. 10, 826836.
  • Victoroff J. I., Benson F., Grafton S. T., Engel J. and Mazziotta J. C. (1994) Electroencephalography and cerebral metabolic correlates. Arch. Neurol. 51, 155163.
  • Vinton A. B., Carne R., Hicks R. J., Desmond P. M., Kilpatrick C., Kaye A. H. and O’Brien T. J. (2007) The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain 130, 548560.
  • Volterra A. and Meldolesi J. (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6, 626640.
  • Voutsinos-Porche B., Koning E., Clement Y., Kaplan H., Ferrandon A., Motte J. and Nehlig A. (2006) EAAC1 glutamate transporter expression in the rat lithium-pilocarpine model of temporal lobe epilepsy. J. Cereb. Blood Flow Metab. 26, 14191430.
  • Vreugdenhil M., Hoogland G., Van Veelen C. W. and Wadman W. J. (2004) Persistent sodium current in subicular neurons isolated from patients with temporal lobe epilepsy. Eur. J. Neurosci. 19, 27692778.
  • Vyas A., Mitra R., Shankaranarayana Rao B. S. and Chattarju S. (2002) Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 22, 68106818.
  • Weiss S. R. B., Post R. M., Gold P. W., Chrousos G., Sullivan T. L., Walker D. and Pert A. (1986) CRF-induced seizures and behavior: interaction with amygdala kindling. Brain Res. 372, 345351.
  • Wu C. L., Huang L. T., Liou C. W., Wang T. J., Tung Y. R., Hsu H. Y. and Lai M. C. (2001) Lithium-pilocarpine-induced status epilepticus in immature rats result in long-term deficits in spatial learning and hippocampal cell loss. Neurosci. Lett. 312, 113117.
  • Wuerfel J., Krishnamoorthy E. S., Brown R. J., Lemieux L., Koepp M., Tebartz van Elst L. and Trimble M. R. (2004) Religiosity is associated with hippocampal but not amygdala volumes in patients with refractory epilepsy. J. Neurol. Neurosurg. Psychiatry 75, 640642.
  • Yamamoto S., Miyamoto T., Morita N. and Yasuda M. (2002) Depressive disorders preceeding temporal lobe epilepsy. Epilepsy Res. 49, 153156.
  • Yan Q. S., Jobe P. C., Cheong J. H., Ko K. H. and Dailey J. W. (1994a) Role of serotonin in the anticonvulsive effect of fluoxetine in genetically epilepsy-prone rats. Arch. Pharmacol. 350, 149152.
  • Yan Q. S., Jobe P. C. and Dailey J. W. (1994b) Evidence that a serotonergic mechanism is involved in the antiepileptic effect of fluoxetine in genetically epilepsy-prone rats. Eur. J. Pharmacol. 252, 105112.
  • Young A. H. (2006) Antiglucocoticoid treatments for depression. Aust. N. Z. J. Psychiatry 40, 402405.
  • Zhu W. J. and Roper S. N. (2001) Brain-derived neurotrophic factor enhances fast excitatory synaptic transmission in human epileptic dentate gyrus. Ann. Neurol. 50, 188194.
  • Zobel A., Wellmer J., Schulze-Rauschenbach S., Pfeiffer U., Schnell S., Elger C. and Maier W. (2004) Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy. Eur. Arch. Psychiatry Clin. Neurosci. 254, 303311.